Skip to search formSkip to main contentSkip to account menu

67Ga-DOTATOC

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
325. Feasibility of a combination of 90Y/177Lu-Radiopeptide Therapy (Peptide Receptor Radionuclide Therapy – PRRT) and External Beam Radiation Therapy (EBRT) in neuroendocrine tumors (NETs)
2017
2017
Effectiveness of radiolabelled somatostatin analogs (90Y-DOTATOC and 177Lu-DOTATATE) in patients with metastatic neuroendocrine tumors: A single center experience in Mexico
2017
2017
Radio-Guided Surgery with β− Radiation: Tests on Ex-Vivo Specimens
Radio-Guided Surgery (RGS) is a surgical technique aimed at assisting the surgeon to reach as complete a resection of the… 
2016
2016
Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach
To the Editor, A 62 year old patient affected by meningeal metastasis from an esthesioneuroblastoma (ENB) of the nasal fossa was… 
2016
2016
Semi-automatic 3D-volumetry of liver metastases from neuroendocrine tumors to improve combination therapy with 177Lu-DOTATOC and 90Y-DOTATOC.
PURPOSE Patients with neuroendocrine tumors (NET) often present with disseminated liver metastases and can be treated with a… 
2011
2011
Monitoring of perfusion changes after systemic versus selective arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC radiopeptide therapy using contrast-enhanced ultrasound in liver metastatic neuroendocrine…
2011
2011
Intraarterial Treatment of GEP NET: 68Ga-DOTATOC SUV Cannot Predict 90Y-DOTATOC Uptake
Kratochwil and colleagues ([1][1]) demonstrate in their very elegant study that selective intraarterial (i.a.) application of… 
2011
2011
Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
Introduction Peptide receptor radionuclide therapy (PRRT) targeting the somatostatin receptor has emerged as a powerful… 
2009
2009
A novel molecular Fluorescent technique for Imaging the Somatostatin Receptor 2 Using a DOTATOC Lanthanide Conjugate.
2009
2009
Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues
Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumours with YDOTATOC and Lu-DOTATATE is promising. The kidney is… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)